81 – 90 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy
(
- Contribution to journal › Article
-
Mark
Adjuvant therapy in primary GIST: state-of-the-art
(
- Contribution to journal › Scientific review
-
Mark
Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma
(
- Contribution to journal › Article
-
Mark
Pesticide exposure in farming and forestry and the risk of uveal melanoma
(
- Contribution to journal › Article
-
Mark
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
(
- Contribution to journal › Article
-
Mark
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur
(
- Contribution to journal › Article
-
Mark
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor : A Randomized Trial
(
- Contribution to journal › Article
- 2011
-
Mark
Case-control study on the use of mobile and cordless phones and the risk for malignant melanoma in the head and neck region
(
- Contribution to journal › Article
-
Mark
Tolerance Studies of the Max-IV Linac
2011) 2nd International Particle Accelerator Conference, 2011(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Study of some Design Concepts and Collective Effects in the MAX IV Linac
2011) 2nd International Particle Accelerator Conference, 2011(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding